跳至主要内容
临床试验/NCT01128270
NCT01128270已完成1 期

Pharmacotoxicology of Trichloroethylene Metabolites Aim 3

University of Florida1 个研究点 分布在 1 个国家目标入组 27 人开始时间: 2010年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
27
试验地点
1
主要终点
Plasma DCA (Microgram/ml) After 5 Days of Therapeutic Level Chloral Hydrate on Arm 2A.

研究概览

简要总结

This is a research study to look at how Dichloroacetate (DCA), and investigational drug and chloral hydrate are broken down in the body. The purpose of the study is to better understand how humans metabolize these two common chemicals that are widely present in the environment. The study focuses on how the drug chloral hydrate is broken down and how it effects DCA

详细描述

The subject's general health is assessed by a history and physical exam and routine blood work. I normal the individual undergoes five nights of receiving 1.5ug/kg of chloral hydrate. On day 6 the individual receives 2.5 micrograms/kg of Dichloroacetate (DCA) and kinetics are drawn. After 30 days the subject comes back and receives 1.5ug/kg of chloral hydrate for five nights and has kinetics drawn on night one and five. On days 6-9 the subject returns for a blood draw. After 30 days the same process as above is done except the subject receives 1gram of chloral hydrate for five nights and 25mg/kg of Dichloroacetate one day then 30 days later the subject receives 1gram of chloral hydrate for five nights and has kinetics done on night one and five and blood samples drawn on days 6-9

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Basic Science
盲法
None

入排标准

年龄范围
21 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • normal screening labs

排除标准

  • no gastrointestinal surgery
  • no smoking
  • no medication
  • not pregnant

研究组 & 干预措施

1A: Chloral Hydrate and DCA: Env

Experimental

Subjects consume Chloral Hydrate 1.5ug/kg by mouth for 5 nights. On the 6th day they consume DCA 2.5ug/kg by mouth and have blood samples drawn. (Period 1)

干预措施: Dichloroacetate environmental dose (Drug)

1A: Chloral Hydrate and DCA: Env

Experimental

Subjects consume Chloral Hydrate 1.5ug/kg by mouth for 5 nights. On the 6th day they consume DCA 2.5ug/kg by mouth and have blood samples drawn. (Period 1)

干预措施: Chloral Hydrate environmental dose (Drug)

1B: Chloral Hydrate Env dose

Experimental

Drug Study Subjects are admitted to the clinical research unit and receive 1.5 ug/kg (environmental dose) of Chloral Hydrate for 5 nights. Pharmacokinetics are done on days 1 and day 5. (Period 2)

干预措施: Chloral Hydrate environmental dose (Drug)

2A: Chloral Hydrate and DCA therapeutic

Experimental

Drug Study Subjects are admitted to the clinical research center and receive a clinical dose of Chloral Hydrate for 5 nights (25mg/kg). On day 6 they are given a clinical dose (25mg/kg)of Dichloroacetate. (Period 3)

干预措施: Dichloroacetate therapeutic dose (Drug)

2A: Chloral Hydrate and DCA therapeutic

Experimental

Drug Study Subjects are admitted to the clinical research center and receive a clinical dose of Chloral Hydrate for 5 nights (25mg/kg). On day 6 they are given a clinical dose (25mg/kg)of Dichloroacetate. (Period 3)

干预措施: Chloral Hydrate therapeutic dose (Drug)

2B: Chloral Hydrate Therapeutic

Experimental

Subjects are given 25 mg/kg of Chloral Hydrate for five nights. Pharmacokinetics are done on days 1 and 5. (Period 4)

干预措施: Chloral Hydrate therapeutic dose (Drug)

结局指标

主要结局

Plasma DCA (Microgram/ml) After 5 Days of Therapeutic Level Chloral Hydrate on Arm 2A.

时间窗: 6 Days

After 5 days of of therapeutic level Chloral Hydrate, the levels of Dichloroacetate in the plasma were measured.

Difference in Half Lives 5 Day Less One Day Exposure in Trichloroacetate

时间窗: 5 days

Elimination Half-life Difference on Arm 2B for 13C-Labeled trichloroacetate between day 5 (prolonged exposure) and day 1 (de novo exposure) after therapeutic level exposure to Chloral Hydrate. This outcome only applies to Period 4. Trichloroacetate is a marker, not an intervention.

Urinary Maleylacetone Levels After 5 Day Exposure to Therapeutic Chloral Hydrate (Arm 2B)

时间窗: 5 days

The levels were clinically indetectable at baseline and the question was whether or not substantive levels would be noted at after 5 days exposure to Chloral Hydrate. Detectable, but low levels were detected.

次要结局

  • Detectable DCA After Day 1 in Serum (0=No 1=Yes)(1 day)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验